Added to YB: 2023-02-06
Pitch date: 2023-02-06
MGTA [bullish]
Magenta Therapeutics, Inc.
-14.68%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of September 11, 2023, Magenta Therapeutics, Inc. was acquired by Dianthus Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$42.2M
Pitch Price
$13.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.62
P/E
-0.61
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
MAGENTA THRPUTCS INC MGTA
A summary for this pitch has not been created yet.
Read full article (0 min)